Progression of classic Kaposi's sarcoma with rituximab

Journal of the American Academy of Dermatology

Volumn 53, Issue 1, 2005, Pages 155-157

  Clifford, Keri S ^a   Demierre, Marie France ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; PREDNISONE; RITUXIMAB;

AGED; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; B LYMPHOCYTE; CASE REPORT; CELL FUNCTION; CELL INTERACTION; CELLULAR IMMUNITY; DERMATOLOGY; DISEASE COURSE; DISEASE EXACERBATION; HUMAN; KAPOSI SARCOMA; MALE; PANCYTOPENIA; PRIORITY JOURNAL; T LYMPHOCYTE;

AGED; AGED, 80 AND OVER; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL; DISEASE PROGRESSION; HUMANS; IMMUNOLOGIC FACTORS; MALE; SARCOMA, KAPOSI; SKIN NEOPLASMS;

EID: 20444482727     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.12.048     Document Type: Article

References (14)

1. P. Geraminejad, O. Memar, I. Aronson, P.L. Rady, U. Hengge, and S.K. Tyring Kaposi's sarcoma and other manifestations of human herpesvirus 8 J Am Acad Dermatol 47 2002 641 655
2. K. Antman, and Y. Chang Kaposi's sarcoma N Engl J Med 342 2000 1027 1038
3. W. Rastetter, A. Molina, and C.A. White Rituximab: expanding role in therapy for lymphomas and autoimmune disease Annu Rev Med 55 2004 477 503
4. A.G. Marcelin, L. Aaron, C. Mateus, E. Gyan, I. Gorin, and J.P. Viard Rituximab therapy for HIV-associated Castleman disease Blood 102 2003 2786 2788
5. E. Voog, F. Morschhauser, and P. Solal-Celigny Neutropenia in patients treated with rituximab N Engl J Med 348 2003 2691 2694
6. Waknine Y. Rituxan may be associated with HBV reactivation and fulminant hepatitis. Medscape Medical News, Oct 9, 2004. Available at: http://www.medscape.com/viewarticle/490970. Accessed Oct 18, 2004.
7. L. Borradori, T. Lombardi, J. Samson, C. Girardet, J.H. Saurat, and A. Hugli Anti-CD20 monoclonal antibody (Rituximab) for refractory erosive stomatitis secondary to CD20+ follicular lymphoma-associated paraneoplastic pemphigus Arch Dermatol 137 2001 269 272
8. L. Heinzerling, R. Dummer, W. Kempf, M.H. Schmid, and G. Burg Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma Arch Dermatol 136 2000 374 378
9. B.L. Brogan, J.A. Zic, M.C. Kinney, J.Y. Hu, K.S. Hamilton, and J.P. Greer Large B-cell lymphoma of the leg: clinical and pathologic characteristics in a North American series J Am Acad Dermatol 49 2003 223 228
10. M. Fierro, P. Savoia, P. Quaglino, M. Novelli, M. Barberis, and M.G. Bernengo Systemic therapy with cyclophosphamide and anti-CD20 antibody (rituximab) in relapsed primary cutaneous B-cell lymphoma: a report of 7 cases J Am Acad Dermatol 49 2003 281 287
11. T.G. Salopek, S. Logsetty, and E.E. Tredget Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder J Am Acad Dermatol 47 2002 785 788
12. A. Espana, M. Fernandez-Galar, P. Lloret, A. Sanchez-Ibarrola, and C. Panizo Long-term complete remission of severe pemphigus vulgaris with monoclonal anti-CD20 antibody therapy and immunophenotype correlations J Am Acad Dermatol 50 2004 974 976
13. A. Dupuy, M. Viguier, C. Bedane, F. Cordoliani, S. Blaise, and F. Aucouturier Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody) Arch Dermatol 140 2004 91 96
14. K. Saigal, I.C. Valencia, J. Cohen, and F.A. Kerdel Hypocomplementemic urticarial vasculitis with angioedema, a rare presentation of systemic lupus erythematosus: rapid response to rituximab J Am Acad Dermatol 49 2003 S283 S285